As one of the most established and renowned companies for contract development and manufacturing, Lonza Pharma & Biotech (LPB) is recognized for reliable, high-quality services, global capacity, innovative technology platforms, and extensive experience. Our products and services span the value chain for drug development and production: from cell lines, media and support for research laboratories, through clinical development and license applications, to pre-clinical and clinical production, all the way to commercialization.
We have expertise in small molecules, biologics (including ADCs and other complex biologics) and emerging therapies such as cell and gene therapy. We produce drug substance and drug product, and offer drug formulation and supply oral solid, finished and packaged medicines to our clients.
Our clients include big pharma, small- to mid-cap pharma and biotech as well as start-ups and research labs. In 2019 alone, we supported over 730 pre-clinical and clinical development programs and provided manufacturing services for over 310 commercial products across small and large molecules.
We have always anticipated and adapted to changing marketplaces. We believe that if you want to deliver the future, you have to shape it. So we continuously invest in our technologies, our assets and our people, to enable our customers to deliver for patients.